School of Medicine
Showing 11-17 of 17 Results
-
Javier Perez-Garcia
Postdoctoral Scholar, Epidemiology
BioJavier Perez-Garcia is a postdoctoral scholar in the Department of Epidemiology and Population Health at Stanford University. His research has been focused on the integration of multi-omic data (e.g., genomics, epigenomics, transcriptomics, and microbiome) to identify potential biomarkers of treatment response for complex diseases like asthma. His research background includes experience both in molecular biology techniques (e.g., DNA extraction and sequencing libraries preparation) and bioinformatic analyses (e.g., processing of raw omic data, association studies at genomic scale, or multi-omic integration through machine learning and quantitative trait loci analyses). He holds a Ph.D. in Health Sciences and a B.Sc. in Pharmacy from the University of La Laguna (Spain).
-
Marcela Radtke
Postdoctoral Scholar, Epidemiology
BioMarcela D. Radtke, PhD earned her doctorate in nutritional biology with an emphasis in cognitive neuroscience from the University of California, Davis. She is a postdoctoral research fellow in the Department of Epidemiology & Population Health at Stanford University School of Medicine and completed a specialized fellowship in the Department of Pediatrics. Dr. Radtke’s research leverages innovative, non-invasive technology within existing healthcare systems to provide objective biomarkers of nutritional status, evaluating the effectiveness of Food is Medicine interventions in the prevention and management of nutrition-sensitive chronic diseases across the lifespan. Her research is supported by the National Institute of Diabetes and Digestive and Kidney Disease (K99/R00) and the World Cancer Research Fund International INSPIRE Research Award.
-
Rasmus Stenlid
Postdoctoral Scholar, Epidemiology
BioRasmus Stenlid, MD, RD, PhD, is a Postdoctoral Researcher in the Department of Epidemiology and Population Health at Stanford School of Medicine. A physician by training, Dr. Stenlid’s research focuses on preventing and treating diabetes, obesity, and heart disease. His research includes randomized clinical trials, with an emphasis on GLP-1 therapies and nutritional interventions. In addition, Dr. Stenlid investigates biomarkers of future cardiovascular events, as well as the pathophysiological links between obesity, diabetes, and cardiovascular disease.